Upper gastrointestinal bleeding: incidence, etiology and outcomes in a population-based setting

References

• Rockall TA, Logan RF, Devlin HB, Northfield TC. Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United Kingdom. Steering Committee and members of the National Audit of Acute Upper Gastrointestinal Haemorrhage. BMJ 1995;311:222–6.
   PubMed Web of Science ®Google Scholar
• Blatchford O, Davidson LA, Murray WR, Blatchford M, Pell J. Acute upper gastrointestinal haemorrhage in west of Scotland: case ascertainment study. BMJ 1997;315:510–14.
   PubMed Web of Science ®Google Scholar
• van Leerdam ME, Vreeburg EM, Rauws EA, Geraedts AA, Tijssen JG, Reitsma JB, Acute upper GI bleeding: did anything change? Time trend analysis of incidence and outcome of acute upper GI bleeding between 1993/1994 and 2000. Am J Gastroenterol 2003;98:1494–9.
   PubMed Web of Science ®Google Scholar
• Button LA, Roberts SE, Evans PA, Goldacre MJ, Akbari A, Dsilva R, Hospitalized incidence and case fatality for upper gastrointestinal bleeding from 1999 to 2007: a record linkage study. Aliment Pharmacol Ther 2011;33:64–76.
   PubMed Web of Science ®Google Scholar
• Paspatis GA, Konstantinidis K, Chalkiadakis I, Tribonias G, Chlouverakis G, Roussomoustakaki M. Changing trends in acute upper gastrointestinal bleeding in Crete, Greece: a population-based study. Eur J Gastroenterol Hepatol 2012;24:102–3.
   PubMed Web of Science ®Google Scholar
• Longstreth GF. Epidemiology of hospitalization for acute upper gastrointestinal hemorrhage: a population-based study. Am J Gastroenterol 1995;90:206–10.
   PubMed Web of Science ®Google Scholar
• Lanas A, Garcia-Rodriguez LA, Polo-Tomas M, Ponce M, Alonso-Abreu I, Perez-Aisa MA, Time trends and impact of upper and lower gastrointestinal bleeding and perforation in clinical practice. Am J Gastroenterol 2009;104:1633–41.
   PubMed Web of Science ®Google Scholar
• Loperfido S, Baldo V, Piovesana E, Bellina L, Rossi K, Groppo M, Changing trends in acute upper-GI bleeding: a population-based study. Gastrointest Endosc 2009;70:212–24.
   PubMed Web of Science ®Google Scholar
• Theocharis GJ, Thomopoulos KC, Sakellaropoulos G, Katsakoulis E, Nikolopoulou V. Changing trends in the epidemiology and clinical outcome of acute upper gastrointestinal bleeding in a defined geographical area in Greece. J Clin Gastroenterol 2008;42:128–33.
   PubMed Web of Science ®Google Scholar
• Paspatis GA, Matrella E, Kapsoritakis A, Leontithis C, Papanikolaou N, Chlouverakis GJ, An epidemiological study of acute upper gastrointestinal bleeding in Crete, Greece. Eur J Gastroenterol Hepatol 2000;12:1215–20.
   Google Scholar
• Yavorski RT, Wong RK, Maydonovitch C, Battin LS, Furnia A, Amundson DE. Analysis of 3,294 cases of upper gastrointestinal bleeding in military medical facilities. Am J Gastroenterol 1995;90:568–73.
   PubMed Web of Science ®Google Scholar
• Czernichow P, Hochain P, Nousbaum JB, Raymond JM, Rudelli A, Dupas JL, Epidemiology and course of acute upper gastro-intestinal haemorrhage in four French geographical areas. Eur J Gastroenterol Hepatol 2000;12:175–81.
   Google Scholar
• Thomopoulos KC, Vagenas KA, Vagianos CE, Margaritis VG, Blikas AP, Katsakoulis EC, Changes in aetiology and clinical outcome of acute upper gastrointestinal bleeding during the last 15 years. Eur J Gastroenterol Hepatol 2004;16:177–82.
   PubMed Web of Science ®Google Scholar
• Ahsberg K, Hoglund P, Kim WH, von Holstein CS. Impact of aspirin, NSAIDs, warfarin, corticosteroids and SSRIs on the site and outcome of non-variceal upper and lower gastrointestinal bleeding. Scand J Gastroenterol 2010;45:1404–15.
   PubMed Web of Science ®Google Scholar
• Hernandez-Diaz S, Rodriguez LA. Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990s. Arch Intern Med 2000;160:2093–9.
   PubMed Web of Science ®Google Scholar
• Wilcox CM, Alexander LN, Cotsonis GA, Clark WS. Nonsteroidal antiinflammatory drugs are associated with both upper and lower gastrointestinal bleeding. Dig Dis Sci 1997;42:990–7.
   PubMed Web of Science ®Google Scholar
• Hallas J, Dall M, Andries A, Andersen BS, Aalykke C, Hansen JM, Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population-based case-control study. BMJ 2006;333:726.
   PubMed Web of Science ®Google Scholar
• Garcia Rodriguez LA, Lin KJ, Hernandez-Diaz S, Johansson S. Risk of upper gastrointestinal bleeding with low-dose acetylsalicylic acid alone and in combination with clopidogrel and other medications. Circulation 2011;123:1108–15.
   PubMed Web of Science ®Google Scholar
• Sorensen HT, Mellemkjaer L, Blot WJ, Nielsen GL, Steffensen FH, McLaughlin JK, Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin. Am J Gastroenterol 2000;95:2218–24.
   PubMed Web of Science ®Google Scholar
• de Abajo FJ, Garcia-Rodriguez LA. Risk of upper gastrointestinal tract bleeding associated with selective serotonin reuptake inhibitors and venlafaxine therapy: interaction with nonsteroidal anti-inflammatory drugs and effect of acid-suppressing agents. Arch Gen Psychiatry 2008;65:795–803.
   PubMed Web of Science ®Google Scholar
• Targownik LE, Bolton JM, Metge CJ, Leung S, Sareen J. Selective serotonin reuptake inhibitors are associated with a modest increase in the risk of upper gastrointestinal bleeding. Am J Gastroenterol 2009;104:1475–82.
   PubMed Web of Science ®Google Scholar
• Tata LJ, Fortun PJ, Hubbard RB, Smeeth L, Hawkey CJ, Smith CJ, Does concurrent prescription of selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs substantially increase the risk of upper gastrointestinal bleeding? Aliment Pharmacol Ther 2005;22:175–81.
   PubMed Web of Science ®Google Scholar
• Wessinger S, Kaplan M, Choi L, Williams M, Lau C, Sharp L, Increased use of selective serotonin reuptake inhibitors in patients admitted with gastrointestinal haemorrhage: a multicentre retrospective analysis. Aliment Pharmacol Ther 2006;23:937–44.
   PubMed Web of Science ®Google Scholar
• Barbui C, Andretta M, De Vitis G, Rossi E, D'Arienzo F, Mezzalira L, Antidepressant drug prescription and risk of abnormal bleeding: a case-control study. J Clin Psychopharmacol 2009;29:33–8.
   PubMedGoogle Scholar
• Etminan M, Levesque L, Fitzgerald JM, Brophy JM. Risk of upper gastrointestinal bleeding with oral bisphosphonates and non steroidal anti-inflammatory drugs: a case-control study. Aliment Pharmacol Ther 2009;29:1188–92.
   Google Scholar
• Donahue JG, Chan KA, Andrade SE, Beck A, Boles M, Buist DS, Gastric and duodenal safety of daily alendronate. Arch Intern Med 2002;162:936–42.
   Google Scholar
• Bauer DC, Black D, Ensrud K, Thompson D, Hochberg M, Nevitt M, Upper gastrointestinal tract safety profile of alendronate: the fracture intervention trial. Arch Intern Med 2000;160:517–25.
   PubMed Web of Science ®Google Scholar
• Hearnshaw SA, Logan RF, Lowe D, Travis SP, Murphy MF, Palmer KR. Acute upper gastrointestinal bleeding in the UK: patient characteristics, diagnoses and outcomes in the 2007 UK audit. Gut 2011;60:1327–35.
   PubMed Web of Science ®Google Scholar
• Peura DA, Lanza FL, Gostout CJ, Foutch PG. The American College of Gastroenterology Bleeding Registry: preliminary findings. Am J Gastroenterol 1997;92:924–8.
   PubMed Web of Science ®Google Scholar
• Hagstofa Íslands (Statistics Iceland). Available at http://hagstofa.is/Hagtolur/Mannfjoldi.
   Google Scholar
• Rockall TA, Logan RF, Devlin HB, Northfield TC. Risk assessment after acute upper gastrointestinal haemorrhage. Gut 1996;38:316–21.
   PubMed Web of Science ®Google Scholar
• Icelandic Medicines Agency (Lyfjastofnun). Available at http://www.imca.is/imca/statistics/2012.
   Google Scholar
• Valkhoff VE, Coloma P, Mosseveld M, Kuipers EJ, Sturkenboom MC, Trifiro G. Su1803 validation of the diagnosis for upper gastrointestinal bleeding in a Dutch medical record database. Gastroenterology 2012;142:S-507.
   Google Scholar
• Enestvedt BK, Gralnek IM, Mattek N, Lieberman DA, Eisen G. An evaluation of endoscopic indications and findings related to nonvariceal upper-GI hemorrhage in a large multicenter consortium. Gastrointest Endosc 2008;67:422–9.
   PubMed Web of Science ®Google Scholar
• Delaney JA, Opatrny L, Brophy JM, Suissa S. Drug–drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding. CMAJ 2007;177:347–51.
   PubMed Web of Science ®Google Scholar
• Carson JL, Strom BL, Soper KA, West SL, Morse ML. The association of nonsteroidal anti-inflammatory drugs with upper gastrointestinal tract bleeding. Arch Intern Med 1987;147:85–8.
   PubMedGoogle Scholar
• Sostres C, Gargallo CJ, Arroyo MT, Lanas A. Adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs, aspirin and coxibs) on upper gastrointestinal tract. Best Pract Res Clin Gastroenterol 2010;24:121–32.
   PubMed Web of Science ®Google Scholar
• Wilcox CM, Clark WS. Association of nonsteroidal antiinflammatory drugs with outcome in upper and lower gastrointestinal bleeding. Dig Dis Sci 1997;42:985–9.
   PubMedGoogle Scholar
• Andrade C, Sandarsh S, Chethan KB, Nagesh KS. Serotonin reuptake inhibitor antidepressants and abnormal bleeding: a review for clinicians and a reconsideration of mechanisms. J Clin Psychiatry 2010;71:1565–75.
   PubMed Web of Science ®Google Scholar
• van Walraven C, Mamdani MM, Wells PS, Williams JI. Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort study. BMJ 2001;323:655–8.
   PubMed Web of Science ®Google Scholar
• Dalton SO, Johansen C, Mellemkjaer L, Norgard B, Sorensen HT, Olsen JH. Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study. Arch Intern Med 2003;163:59–64.
   PubMed Web of Science ®Google Scholar